Apollo Hospitals Q2 Results: Net Profit Rises 32% to ₹630 Crore
Apollo Hospitals Q2 results: net profit jumps 32% to ₹630 crore as revenue rises 23% to ₹7,615 crore on higher occupancy and HealthCo growth.
The Apollo Hospitals Q2 results, announced on Wednesday, 4 November, showed consolidated net profit rising 32% to ₹630 crore for the July–September quarter, as revenue grew 23% to ₹7,615 crore.
Net profit stood at ₹477 crore in the same quarter last year, according to Business Standard. Consolidated EBITDA rose 29% to ₹1,191 crore from ₹924 crore, so earnings grew faster than the top line. Diluted earnings per share from continuing operations came in at ₹43.71.
The EBITDA figure includes ₹91 crore of costs linked to the Apollo 24/7 digital platform, including a non-cash ESOP charge, Kotak Neo reported. The Chennai-based group, founded by Dr Prathap C Reddy, is one of India’s largest private hospital chains.
Hospitals drive Apollo Hospitals net profit growth
The healthcare services business, which runs the group’s hospitals, remained the main profit engine. Its revenue rose 23% to ₹3,900 crore from ₹3,169 crore, while segment EBITDA climbed 20% to ₹937 crore from ₹780 crore.
Segment net profit increased 19% to ₹486 crore from ₹408 crore. Overall occupancy reached 73%, up from 69% a year earlier, and touched 76% at established units.
Inpatient volumes in the hospitals business rose 14%, and average revenue per patient increased 8% to ₹1,86,880, Kotak Neo reported. Revenue from international patients jumped 37%.
Group Chief Financial Officer Krishnan Akhileswaran attributed the performance to volume growth, pricing levers and a changing case mix. Oncology revenue grew 28% and gastroenterology 27%, while cardiac care and orthopaedics each grew 20%. The company also pointed to a rebound in patient inflows from Bangladesh, along with traction from Africa.
Apollo HealthCo and diagnostics add momentum
Apollo HealthCo, which houses the pharmacy distribution and digital health operations, posted revenue of ₹3,286 crore, up 23%, with EBITDA of ₹193 crore and net profit of ₹118 crore, according to Kotak Neo. The unit added 222 net new pharmacy stores during the quarter, taking its network to 7,662.
Gross merchandise value (GMV) of the Apollo 24/7 platform’s core business rose 27% to ₹571 crore from ₹450 crore in the year-ago quarter. Total Apollo 24/7 GMV grew 20%.
Apollo Health and Lifestyle (AHLL), the diagnostics and retail healthcare arm, grew revenue 20% to ₹429 crore. Diagnostics revenue alone rose 24% to ₹227 crore. AHLL reported a net profit of ₹26 crore, against a loss in the same period last year.
Why the Apollo Hospitals Q2 results matter for investors
Apollo is a Nifty 50 constituent, and its quarterly numbers are closely watched as a gauge of demand for private hospital care in India. A 32% profit jump on 23% revenue growth suggests that higher occupancy and strong growth in key specialities are lifting returns, even as the group keeps spending on its digital business.
The turnaround at AHLL and steady store additions at HealthCo also reduce the group’s dependence on hospitals alone. For investors, a key question has been whether the digital and pharmacy bets will keep diluting margins; this quarter offers some early evidence that the drag is narrowing.
The shares closed at ₹8,599.50 on the NSE on Wednesday, up 1.89%, before the Apollo Hospitals Q2 results were announced after market hours, Kotak Neo reported. The numbers arrive in a busy results week for large companies that also included ITC’s Q2 results.
Expansion plans and what comes next
Apollo plans to add about 5,800 capacity beds, or about 4,700 census beds, over the next five years. About ₹7,100 crore of the planned project cost of ₹11,152 crore is still to be spent.
The 180-bed Sarjapur hospital in Bengaluru was recently commissioned, while facilities at Financial District in Hyderabad and Sonarpur in Kolkata are ramping up. The roughly 470-bed Gurugram facility remains on track for commissioning in Q3 FY27, the company said.
Also Read: NTPC Q2 Results: Profit Rises 38.7% to ₹7,030 Crore; ₹3 Dividend
Investors will track how quickly the newer hospitals fill their beds, since fresh capacity typically weighs on margins in its early months. The timing of the Gurugram launch, along with further gains in digital profitability, will shape Apollo’s earnings over the rest of FY27. More such reports are available in our latest business news section.
